PIVA, Roberto
PIVA, Roberto
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins
2005-01-01 PIVA R; GIANFERRETTI P; CIUCCI A; TAULLI R; BELARDO G; SANTORO MG
A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum.
1999-01-01 MIGHELI A ;PIVA R ;CASOLINO S ;ATZORI C ;DLOUHY SR ;GHETTI B
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
2015-01-01 Abate, F.; Todaro, M.; Van Der Krogt, J.-A.; Boi, M.; Landra, I.; Machiorlatti, R.; Tabbò, F.; Messana, K.; Abele, C.; Barreca, A.; Novero, D.; Gaudiano, M.; Aliberti, S.; Di Giacomo, F.; Tousseyn, T.; Lasorsa, E.; Crescenzo, R.; Bessone, L.; Ficarra, E.; Acquaviva, A.; Rinaldi, A.; Ponzoni, M.; Longo, D.L.; Aime, S.; Cheng, M.; Ruggeri, B.; Piccaluga, P.P.; Pileri, S.; Tiacci, E.; Falini, B.; Pera-Gresely, B.; Cerchietti, L.; Iqbal, J.; Chan, W.C.; Shultz, L.D.; Kwee, I.; Piva, R.; Wlodarska, I.; Rabadan, R.; Bertoni, F.; Inghirami, G.
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
2006-01-01 PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice
2004-01-01 BENDOTTI C; ATZORI C; PIVA R; TORTAROLO M; STRONG MJ; DEBIASI S; MIGHELI A
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.
2001-01-01 ATZORI C ;GHETTI B ;PIVA R ;SRINIVASAN AN ;ZOLO P ;DELISLE MB ;MIRRA SS ;MIGHELI A
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
2012-01-01 Tabbó F; Barreca A; Piva R; Inghirami G; The European T-Cell Lymphoma Study Group (;Riccardo Bruna; Daniele Corino; Diego Cortese; Ramona Crescenzo; Giuditta Cuccuru; Filomena di Giacomo; Alessandro Fioravanti; Marco Ladetto; Indira Landra; Katia Messana; Rodolfo Machiorlatti; Barbara Martinoglio; Enzo Medico; Marta Mossino; Elisa Pellegrino; Maria Todaro; Paola Campisi; Luigi Chiusa; Annalisa Chiappella; Domenico Novero; Umberto Vitolo; Francesco Abate; Andrea Acquaviva; Elisa Ficarra; Roberto Freilone; Marco Chilosi; Alberto Zamó; Fabio Facchetti; Silvia Lonardi; Anna De Chiara; Franco Fulciniti; Claudio Doglioni; Maurilio Ponzoni; Luca Agnelli; Antonino Neri; Katia Todoerti; Claudio Agostinelli; Pier Paolo Piccaluga; Stefano Pileri; Brunangelo Falini; Enrico Tiacci; Peter Van Loo; Thomas Tousseyn; Christiane De Wolf-Peeters; Eva Geissinger; Hans Konrad Muller-Hermelink; Andreas Rosenwald; Miguel Angel Piris; Maria E. Rodriguez; Francesco Bertoni; Michela Boi; Ivo Kwee;)
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis
2014-01-01 Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
2009-01-01 Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Anaplastic large-cell lymphoma
2011-01-01 Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME.
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
2002-01-01 ZAMO A; R. CHIARLE; PIVA R; HOWES J; FAN Y; CHILOSI M; LEVY DE; INGHIRAMI G.
Anaplastic lymphoma kinase in human cancer
2011-01-01 Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group;(Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME)
bcl-2 protein expression in aged brain and neurodegenerative diseases.
1994-01-01 MIGHELI A; CAVALLA P; PIVA R; GIORDANA MT; SCHIFFER D
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors
2019-01-01 Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio
c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis.
1997-01-01 MIGHELI A ;PIVA R ;ATZORI C ;TROOST D ;SCHIFFER D
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation
2005-01-01 Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G
CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas.
1998-01-01 PIVA R ;CAVALLA P ;BORTOLOTTO S ;CORDERA S ;GROSSO R ;RICHIARDI P ;DUTTO A ;SCHIFFER D
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors.
1999-01-01 SCHIFFER D ;BORTOLOTTO S ;BOSONE I ;CANCELLI I ;CAVALLA P ;SCHIFFER P ;PIVA R
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib
2008-01-01 Piva R; Ruggeri B; Williams M;Costa G;Tamagno I; Ferrero D; Giai V; Coscia M; Peola S; Massaia M;Pezzoni G; Allievi C; Pescalli N; Cassin M; di Giovine S; Nicoli P;de Feudis P; Strepponi I; Roato I; Ferracini R; Bussolati B; Camussi G; Jones-Bolin S; Hunter K; Zhao H; Neri A; Palumbo A; Berkers C; Ovaa H; Bernareggi A; Inghirami G
Characterization of murine Girk2 transcript isoforms: structure and differential expression.
1998-01-01 WEI J ;HODES ME ;PIVA R ;FENG Y ;WANG Y ;GHETTI B ;DLOUHY SR
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins | 2005 | PIVA R; GIANFERRETTI P; CIUCCI A; TAULLI R; BELARDO G; SANTORO MG | |
| A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. | 1999 | MIGHELI A ;PIVA R ;CASOLINO S ;ATZORI C ;DLOUHY SR ;GHETTI B | |
| A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation | 2015 | Abate, F.; Todaro, M.; Van Der Krogt, J.-A.; Boi, M.; Landra, I.; Machiorlatti, R.; Tabbò, F.; Messana, K.; Abele, C.; Barreca, A.; Novero, D.; Gaudiano, M.; Aliberti, S.; Di Giacomo, F.; Tousseyn, T.; Lasorsa, E.; Crescenzo, R.; Bessone, L.; Ficarra, E.; Acquaviva, A.; Rinaldi, A.; Ponzoni, M.; Longo, D.L.; Aime, S.; Cheng, M.; Ruggeri, B.; Piccaluga, P.P.; Pileri, S.; Tiacci, E.; Falini, B.; Pera-Gresely, B.; Cerchietti, L.; Iqbal, J.; Chan, W.C.; Shultz, L.D.; Kwee, I.; Piva, R.; Wlodarska, I.; Rabadan, R.; Bertoni, F.; Inghirami, G. | |
| Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas | 2006 | PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G | |
| Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice | 2004 | BENDOTTI C; ATZORI C; PIVA R; TORTAROLO M; STRONG MJ; DEBIASI S; MIGHELI A | |
| Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. | 2001 | ATZORI C ;GHETTI B ;PIVA R ;SRINIVASAN AN ;ZOLO P ;DELISLE MB ;MIRRA SS ;MIGHELI A | |
| ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma | 2012 | Tabbó F; Barreca A; Piva R; Inghirami G; The European T-Cell Lymphoma Study Group (;Riccardo Bruna; Daniele Corino; Diego Cortese; Ramona Crescenzo; Giuditta Cuccuru; Filomena di Giacomo; Alessandro Fioravanti; Marco Ladetto; Indira Landra; Katia Messana; Rodolfo Machiorlatti; Barbara Martinoglio; Enzo Medico; Marta Mossino; Elisa Pellegrino; Maria Todaro; Paola Campisi; Luigi Chiusa; Annalisa Chiappella; Domenico Novero; Umberto Vitolo; Francesco Abate; Andrea Acquaviva; Elisa Ficarra; Roberto Freilone; Marco Chilosi; Alberto Zamó; Fabio Facchetti; Silvia Lonardi; Anna De Chiara; Franco Fulciniti; Claudio Doglioni; Maurilio Ponzoni; Luca Agnelli; Antonino Neri; Katia Todoerti; Claudio Agostinelli; Pier Paolo Piccaluga; Stefano Pileri; Brunangelo Falini; Enrico Tiacci; Peter Van Loo; Thomas Tousseyn; Christiane De Wolf-Peeters; Eva Geissinger; Hans Konrad Muller-Hermelink; Andreas Rosenwald; Miguel Angel Piris; Maria E. Rodriguez; Francesco Bertoni; Michela Boi; Ivo Kwee;) | |
| ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis | 2014 | Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto | |
| Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? | 2009 | Fornari A; Piva R; Chiarle R; Novero D; Inghirami G | |
| Anaplastic large-cell lymphoma | 2011 | Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME. | |
| Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death | 2002 | ZAMO A; R. CHIARLE; PIVA R; HOWES J; FAN Y; CHILOSI M; LEVY DE; INGHIRAMI G. | |
| Anaplastic lymphoma kinase in human cancer | 2011 | Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group;(Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME) | |
| bcl-2 protein expression in aged brain and neurodegenerative diseases. | 1994 | MIGHELI A; CAVALLA P; PIVA R; GIORDANA MT; SCHIFFER D | |
| BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors | 2019 | Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio | |
| c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. | 1997 | MIGHELI A ;PIVA R ;ATZORI C ;TROOST D ;SCHIFFER D | |
| CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation | 2005 | Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G | |
| CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas. | 1998 | PIVA R ;CAVALLA P ;BORTOLOTTO S ;CORDERA S ;GROSSO R ;RICHIARDI P ;DUTTO A ;SCHIFFER D | |
| Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. | 1999 | SCHIFFER D ;BORTOLOTTO S ;BOSONE I ;CANCELLI I ;CAVALLA P ;SCHIFFER P ;PIVA R | |
| CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib | 2008 | Piva R; Ruggeri B; Williams M;Costa G;Tamagno I; Ferrero D; Giai V; Coscia M; Peola S; Massaia M;Pezzoni G; Allievi C; Pescalli N; Cassin M; di Giovine S; Nicoli P;de Feudis P; Strepponi I; Roato I; Ferracini R; Bussolati B; Camussi G; Jones-Bolin S; Hunter K; Zhao H; Neri A; Palumbo A; Berkers C; Ovaa H; Bernareggi A; Inghirami G | |
| Characterization of murine Girk2 transcript isoforms: structure and differential expression. | 1998 | WEI J ;HODES ME ;PIVA R ;FENG Y ;WANG Y ;GHETTI B ;DLOUHY SR |